undamentalytics Newsletter
Sign in

Delcath Systems, Inc. revenue

Delcath Systems, Inc.'s revenue was $85.2m in fiscal 2025, up 129.1% on the year before. Since fiscal 2012 ($346,000) it has grown at a compound 99.0% a year. Over the last twelve months it was $95.4m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue000112432378595
Growth on the year before———+128.3%+35.3%+63.4%+103.5%−23.5%−24.1%+>999%+129.1%—
Gross profit000011321317383
Gross margin——88.7%41.3%72.8%73.6%81.1%74.8%69.2%83.4%86.2%87.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
HEPZATOKIT $78.8M 92.5% ▲ 144.0%
CHEMOSAT $6.4M 7.5% ▲ 30.5%
Geography
Region Revenue Share YoY
United States $78.8M 92.5% ▲ 144.0%
Outside the US $6.4M 7.5% ▲ 30.5%

From Delcath Systems, Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Delcath Systems, Inc. $95.4m 35.8% 230.8%
Iradimed Corp $89.3m 11.0% 12.4%
Ceribell, Inc. $102m 31.7% —
Pulmonx Corp $87.4m -3.4% 13.0%
Sight Sciences, Inc. $83.4m 9.3% 0.8%
Xtant Medical Holdings, Inc. $110m -14.3% 17.3%

Compare with peers

Head to head: DCTH vs IRMDCBLL vs DCTHDCTH vs LUNG

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Delcath Systems, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Delcath Systems, Inc.